IGIM
ABUS icon

I.G. Investment Management’s Arbutus Biopharma ABUS Stock Holding History

I.G. Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-250,000
Closed -$870K – 891
2016
Q2 		$870K Buy
+250,000
New +$1.06M ﹤0.01% 675
2015
Q1 		– Sell
-63,750
Closed -$976K – 859
2014
Q4 		$976K Buy
+63,750
New +$1.1M ﹤0.01% 641
2014
Q3 		– Sell
-63,750
Closed -$831K – 843
2014
Q2 		$831K Hold
63,750
– – ﹤0.01% 662
2014
Q1 		$1.38M Hold
63,750
– – 0.01% 510
2013
Q4 		$507K Hold
63,750
– – ﹤0.01% 692
2013
Q3 		$445K Sell
63,750
-86,250
-58% -$475K ﹤0.01% 705
2013
Q2 		$691K Buy
+150,000
New +$710K ﹤0.01% 627

Other funds holding ABUS

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return